{"id":9802,"date":"2021-06-02T09:04:01","date_gmt":"2021-06-02T07:04:01","guid":{"rendered":"https:\/\/ggba.swiss\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/"},"modified":"2023-07-04T13:43:37","modified_gmt":"2023-07-04T11:43:37","slug":"specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/","title":{"rendered":"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions"},"content":{"rendered":"<p>Fond\u00e9e en 2019, <a href=\"https:\/\/www.earlysight.com\/\" target=\"_blank\" rel=\"noopener\">EarlySight<\/a> utilise une approche in\u00e9dite pour fournir une imagerie au niveau d&rsquo;une seule cellule du fond de l&rsquo;\u0153il, dit r\u00e9tine. Sa technologie combine mat\u00e9riel et logiciel pour proposer un dispositif m\u00e9dical unique permettant d&rsquo;observer les cellules affect\u00e9es au stade pr\u00e9coce des maladies r\u00e9tiniennes les plus r\u00e9pandues telles que la d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l&rsquo;\u00e2ge, le glaucome ou la r\u00e9tinopathie diab\u00e9tique, afin de les traiter plus t\u00f4t et plus efficacement.<\/p>\n<p>La spin-off de l&rsquo;<a href=\"https:\/\/www.epfl.ch\/fr\/\" target=\"_blank\" rel=\"noopener\">EPFL<\/a> a annonc\u00e9 la cl\u00f4ture d&rsquo;un tour de financement de CHF 2,3 millions sur un total de CHF 3 millions de financement d&rsquo;amor\u00e7age men\u00e9 par <a href=\"https:\/\/www.verve.vc\/\" target=\"_blank\" rel=\"noopener\">Verve Ventures<\/a> avec la participation de <a href=\"https:\/\/www.nina.capital\/\" target=\"_blank\" rel=\"noopener\">Nina Capital<\/a>, un fonds europ\u00e9en de technologies pour la sant\u00e9 en phase de d\u00e9marrage et d&rsquo;autres investisseurs priv\u00e9s qui ont effectu\u00e9 un investissement de pr\u00e9-amor\u00e7age.<\/p>\n<p>\u00ab\u00a0Le besoin d&rsquo;une compr\u00e9hension plus approfondie et d&rsquo;un diagnostic plus pr\u00e9coce des maladies de la r\u00e9tine ne fera qu&rsquo;augmenter avec les tendances actuelles de vieillissement de la population. Earlysight poss\u00e8de les bons atouts pour r\u00e9pondre \u00e0 ce besoin\u00a0\u00bb, a d\u00e9clar\u00e9 Sebastian Anastassiou de Nina Capital.<\/p>\n<p>Les CHF 2,3 millions obtenus permettront \u00e0 EarlySight de d\u00e9velopper son \u00e9quipe, d&rsquo;optimiser sa technologie et de proc\u00e9der \u00e0 des validations cliniques suppl\u00e9mentaires. En outre, la start-up pr\u00e9voit de franchir des \u00e9tapes importantes pour pr\u00e9parer son entr\u00e9e sur le march\u00e9.<\/p>\n<p>\u00ab\u00a0EarlySight est \u00e9galement tr\u00e8s int\u00e9ressante pour le d\u00e9veloppement pharmaceutique, car l&rsquo;absence de crit\u00e8res cliniques objectifs a rendu difficile le d\u00e9veloppement de traitements pr\u00e9coces. Dans l&rsquo;ensemble, EarlySight a vraiment le potentiel pour devenir la prochaine technologie r\u00e9volutionnaire dans le domaine de l&rsquo;imagerie r\u00e9tinienne, de la m\u00eame mani\u00e8re que l&rsquo;OCT l&rsquo;a \u00e9t\u00e9 il y a 20 ans\u00a0\u00bb, explique Susanne Schorsch, responsable des investissements chez Verve Ventures.<\/p>\n<p>Le tour de financement de l&rsquo;entreprise vaudoise reste ouvert jusqu&rsquo;en juillet pour une deuxi\u00e8me cl\u00f4ture avec un investissement suppl\u00e9mentaire de CHF 600\u2019000.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La spin-off de l&rsquo;EPFL EarlySight a recueilli CHF 2,3 millions pour le d\u00e9veloppement d&rsquo;un dispositif m\u00e9dical qui aide les m\u00e9decins \u00e0 d\u00e9tecter et \u00e0 traiter les maladies oculaires \u00e0 un stade pr\u00e9coce.<\/p>\n","protected":false},"author":3,"featured_media":9803,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1094,1066,1068],"class_list":["post-9802","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-medical-devices-2","tag-optics-fr","tag-personalized-medicine-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"La spin-off de l&#039;EPFL EarlySight a recueilli CHF 2,3 millions pour le d\u00e9veloppement d&#039;un dispositif m\u00e9dical qui aide les m\u00e9decins \u00e0 d\u00e9tecter et \u00e0 traiter les maladies oculaires \u00e0 un stade pr\u00e9coce.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-02T07:04:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions\",\"datePublished\":\"2021-06-02T07:04:01+00:00\",\"dateModified\":\"2023-07-04T11:43:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/\"},\"wordCount\":374,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg\",\"keywords\":[\"Medical Devices\",\"Optics\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/\",\"name\":\"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg\",\"datePublished\":\"2021-06-02T07:04:01+00:00\",\"dateModified\":\"2023-07-04T11:43:37+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/","og_locale":"fr_FR","og_type":"article","og_title":"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions - Greater Geneva Bern area","og_description":"La spin-off de l'EPFL EarlySight a recueilli CHF 2,3 millions pour le d\u00e9veloppement d'un dispositif m\u00e9dical qui aide les m\u00e9decins \u00e0 d\u00e9tecter et \u00e0 traiter les maladies oculaires \u00e0 un stade pr\u00e9coce.","og_url":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2021-06-02T07:04:01+00:00","article_modified_time":"2023-07-04T11:43:37+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions","datePublished":"2021-06-02T07:04:01+00:00","dateModified":"2023-07-04T11:43:37+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/"},"wordCount":374,"image":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg","keywords":["Medical Devices","Optics","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/","url":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/","name":"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg","datePublished":"2021-06-02T07:04:01+00:00","dateModified":"2023-07-04T11:43:37+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-3.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/specialiste-de-detection-maladies-oculaires-earlysight-leve-chf-23-millions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Le sp\u00e9cialiste de la d\u00e9tection des maladies oculaires EarlySight l\u00e8ve CHF 2,3 millions"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=9802"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9802\/revisions"}],"predecessor-version":[{"id":17939,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9802\/revisions\/17939"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/9803"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=9802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=9802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=9802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}